المؤلفون: Krijger PHL; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Hoek TA; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Boersma S; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Donders LIPM; Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands., Broeders MMC; Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands., Pieterse M; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Toonen PW; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Logister I; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Verhagen BMP; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Verstegen MJAM; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., van Ravesteyn TW; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Roymans RJTM; Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands., Mattiroli F; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands., Vandesompele J; InActiv Blue, Beernem, Belgium.; Biogazelle, Zwijnaarde, Belgium., Nijhuis M; Department of Medical Microbiology, University Medical Center, Utrecht, the Netherlands., Meijer S; Tecan labwerx, Tecan Trading AG, Männedorf, Switzerland., van Weert A; National Screening Laboratory Sanquin, Sanquin Diagnostics, Amsterdam, the Netherlands., Dekker E; Bodegro B.V, Breda, the Netherlands., Dom FJ; HiFiBio Therapeutics, Saint-Jacques, France., Ruijtenbeek R; Department of Laboratory Automation, Genmab B.V., Utrecht, the Netherlands., van der Velden LBJ; Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands. l.van.der.velden@pamm.nl., van de Bovenkamp JHB; Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands., Bosch M; Department of Laboratory Automation, Genmab B.V., Utrecht, the Netherlands. mbh@genmab.com., de Laat W; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands. w.laat@hubrecht.eu., Tanenbaum ME; Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands. m.tanenbaum@hubrecht.eu.

المصدر: Nature biotechnology [Nat Biotechnol] 2021 Oct; Vol. 39 (10), pp. 1182-1184.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE

مواضيع طبية MeSH: Delivery of Health Care* , Public-Private Sector Partnerships*, COVID-19/*epidemiology , SARS-CoV-2/*pathogenicity, COVID-19/virology ; Humans